INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2017

Zinc lozenges (>75 mg/day) shortened common cold duration by 33%, with no significant difference between zinc acetate and zinc gluconate or higher doses.

A meta-analysis of seven randomized placebo-controlled trials evaluated zinc lozenges (>75 mg/day) in 575 participants with naturally acquired common colds. Mean common cold duration was 33% (95% CI 21% to 45%) shorter in the zinc groups. Colds were shortened by 40% with zinc acetate (3 trials) and by 28% with zinc gluconate (4 trials), with a non-significant difference of 12 percentage points (95% CI: -12 to +36). Zinc doses of 80-92 mg/day reduced duration by 33% compared to 35% for doses of 192-207 mg/day, a non-significant difference of 2 percentage points (95% CI: -29 to +32).

Study type
Meta-analysis of randomized controlled trials
Who was studied
575 participants with naturally acquired common colds across 7 trials
What was measured
Duration of the common cold

THE PAPER

Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage.

Hemilä H. JRSM Open, 2017.

PubMed 28515951 ↗DOI 10.1177/2054270417694291 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.